Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Using points for low value items can waste your rewards. Discover smarter choices to make the most of your credit card benefits.
24,708 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
NRG Energy announced a transformative deal that doubles its generation capacity to roughly 25 GW and targets 14% annu...
RenoFi closes a $22M Series B to scale its AI-driven renovation financing platform, triple its RENOVATION financing t...
Oro Labs has secured a $100 million Series C to scale its AI-powered procurement orchestration platform, expanding it...
Thinking about investing in artificial intelligence stocks hold for the long run? This article breaks down two depend...
AI is changing every industry—and with the right approach, you can uncover millionaire-maker artificial intelligence ...
Geopolitics can shake travel stocks fast. This article breaks down how Carnival, the world’s largest cruise operator,...
Movement Mortgage’s reverse mortgage division is pursuing modest growth through organic leads and purpose-driven lead...
Daré (DARE) has a developing pipeline and a tight cash runway. This article breaks down what the Q4 2025 earnings cal...
SpaceX’s highly anticipated IPO could reshape the market. This guide explains which stock slated cash spacex, why Alp...
The Seattle Storm has evolved from a secondary act to a leading force in Seattle’s basketball economy, reshaping the ...
I used to be skeptical about SoundHound AI, but new developments and strategic moves are making me reconsider. This a...